Mr. David Matas:

There is a chapter on that written by Arne Schwarz. All major pharmaceutical companies were testing anti-rejection drugs in China. Arne Schwarz is a researcher in Switzerland, where the headquarters of many of these firms are based, and he began a campaign against it. Roche received a Public Eye award as the major corporate culprit of the year in Switzerland because of this abuse. Amnesty International in Switzerland put out a call against this abuse, the testing of anti-rejection drugs in China. Novartis responded to the Amnesty call and suspended all anti-rejection drug tests in China. Pfizer developed a very good policy. Isotechnika Pharma in Canada announced it would carry out trials in China and, because it is a Canadian firm, I kicked up a fuss and it backed down. What pharmaceutical companies do in respect of trials is public information and is on the Internet. They advertise trials, what is going on and what they have done. There is a long history of involvement in China but now there is nothing.